| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 13,190 | $30 | $342.9K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 72,400 | $1 | $289.6K |
| J0897 | Injection, denosumab, 1 mg | 7,750 | $20 | $139.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 16,800 | $10 | $134.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,040 | $100 | $102.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,260 | $10 | $101.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 330 | $100 | $32.5K |
| 99491 | The provider, a physician or other healthcare professional, personally directs the evaluation and management of a patient with two or more chronic A physician or other qualified healthcare… | 330 | $70 | $22.6K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 740 | $30 | $21.5K |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 330 | $50 | $16.4K |